Skip to content
PICO Portalanswers from OpenAlex

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease

PaperCitations, authors & open-access status

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease have?

PICO Portalcitation count

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease has 948 citations in the OpenAlex counts PICO Portal stores.

When was Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease published?

PICO Portalyear

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease has 1999 year in the PICO Portal index.

What is the open-access status of Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease?

PICO Portaloa status

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease has bronze oa status in the PICO Portal index.

What is the DOI of Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease?

PICO Portaldoi

The DOI for Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease is on the source record.

What is the PMID of Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease?

PICO Portalpmid

The PMID for Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease is on the source record.

What is the OpenAlex record for Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease?

PICO Portalopenalex

The OpenAlex for Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial